---
schema_version: "secwatch.filing_event.v1"
accession: "0001588978-26-000002"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:18:25.168772+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M

## Summary
- Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).
- Q4 net loss $29.8M vs $18.9M loss; adjusted EBITDA loss $19.0M vs $10.3M.
- U.S. install base 718 systems (+42% YoY); handpiece ASP $3,340 (+5% sequentially).
- FY 2026 revenue guidance $390-410M (27-33% growth); U.S. procedure growth 39-48%.
- FY 2026 gross margin ~65%; operating expenses ~$350M; adj. EBITDA loss $30-17M.

## SEC filing metadata
- accession: 0001588978-26-000002
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/0001588978-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/prct-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001588978-26-000002
- JSON: https://secwatch.observer/filing/0001588978-26-000002.json
- Plain text: https://secwatch.observer/filing/0001588978-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.